AMT-253 in Patients With Selected Advanced Solid Tumours
NCT 05906862 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 05906862 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forwardNCT 05876754 Brief Summary A Phase 3b research study to consolidate the…
Read more arrow_forwardNCT 03897881 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 03340129 Brief Summary This is a phase II, open label, randomised…
Read more arrow_forwardNCT 03175224 Brief Summary To assess: efficacy of APL-101 as monotherapy for…
Read more arrow_forwardNCT 05807035 Brief Summary Phase 1 trial to evaluate the feasibility of…
Read more arrow_forwardNCT 06106945 Brief Summary This is a Phase I/II, modular, open-label,…
Read more arrow_forwardNCT 06219941 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 04924075 Brief Summary This is a study to evaluate the efficacy…
Read more arrow_forwardNCT 06756932 Brief Summary The purpose of this study is to assess…
Read more arrow_forward